Advanced Medical Solutions Group plc (AIM:AMS)

AIM:AMS Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	608	470	424	451	561	730
Market Cap Growth	39.03%	11.01%	-6.07%	-19.69%	-23.12%	39.54%
Enterprise Value	673	534	379	391	496	680
Last Close Price	2.81	2.16	1.93	2.01	2.48	3.21

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	62.06	47.24	59.71	28.38	27.52	41.78
Forward PE	20.57	16.87	16.08	20.13	23.31	33.87
PS Ratio	2.66	2.05	2.39	3.57	4.52	6.73
PB Ratio	2.34	1.81	1.75	1.85	2.37	3.43
P/TBV Ratio	7.35	5.68	7.95	3.50	4.21	6.29
P/FCF Ratio	24.10	18.64	27.45	51.24	24.27	24.96
P/OCF Ratio	18.66	14.43	21.73	36.53	20.89	23.54
PEG Ratio	0.97	0.95	1.09	2.09	1.46	1.30

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	2.94	2.33	2.13	3.10	3.99	6.26
EV/EBITDA Ratio	16.41	14.41	16.68	14.70	16.02	23.71
EV/EBIT Ratio	29.69	23.56	33.74	20.71	19.91	29.55
EV/FCF Ratio	26.67	21.16	24.53	44.43	21.42	23.23

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.31	0.31	0.36	0.04	0.04	0.05
Debt / EBITDA Ratio	1.99	1.99	3.40	0.32	0.30	0.33
Debt / FCF Ratio	3.23	3.23	5.61	1.04	0.42	0.34
Net Debt / Equity Ratio	0.24	0.24	0.29	-0.21	-0.31	-0.30
Net Debt / EBITDA Ratio	1.71	1.71	3.06	-1.92	-2.34	-2.20
Net Debt / FCF Ratio	2.52	2.52	4.51	-5.80	-3.13	-2.16
Asset Turnover	0.59	0.59	0.52	0.44	0.47	0.45
Inventory Turnover	1.71	1.71	1.86	1.75	2.16	2.36
Quick Ratio	1.29	1.29	1.55	3.84	4.53	5.52
Current Ratio	2.79	2.79	2.85	5.67	5.82	6.76
Return on Equity (ROE)	4.03%	4.03%	2.94%	6.61%	9.08%	8.43%
Return on Assets (ROA)	3.62%	3.62%	2.07%	4.14%	5.86%	5.89%
Return on Invested Capital (ROIC)	3.98%	4.05%	3.23%	7.94%	12.50%	11.83%
Return on Capital Employed (ROCE)	6.60%	6.60%	3.30%	7.10%	9.60%	9.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	1.64%	2.12%	1.68%	3.52%	3.63%	2.39%
FCF Yield	4.15%	5.37%	3.64%	1.95%	4.12%	4.01%
Dividend Yield	1.02%	1.32%	1.34%	1.18%	0.87%	0.61%
Payout Ratio	58.18%	58.18%	73.31%	30.05%	21.27%	22.00%
Buyback Yield / Dilution	-0.78%	-0.78%	0.45%	0.09%	-0.53%	-0.22%
Total Shareholder Return	0.24%	0.54%	1.80%	1.26%	0.33%	0.39%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 28, 2026

Data Sources Report a data error